Search

everythinglearnresearchcommunity

for

Search:↓

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

An 8-year-old boy with hair loss had hair regrowth and responded well to clobetasol propionate treatment.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Diphencyprone therapy can effectively treat severe hair loss in motivated patients.

5 mg/mL of triamcinolone acetonide is most effective for hair regrowth with fewer side effects.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

Atopic dermatitis patients have much higher acetylcholine levels in their skin, which may cause itching.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

A new method accurately measures clobetasol propionate in hair and skin.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

Intralesional triamcinolone acetonide effectively treats acne keloidalis nuchae with minimal side effects.

A CCS patient with severe complications was successfully treated using combined therapies.

Injectable ACell with blood serum/PRP may slow hair loss and regrow thinning hair.

Clofazimine may be effective for treating ashy dermatosis.

Cyclosporine A helps hair grow by blocking a process that would otherwise cause hair cells to die.

High-dose intravenous iron therapy doesn't interfere with treatment improvements in IBD patients with iron deficiency anemia.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Hair samples can reliably monitor tacrolimus levels in kidney transplant patients.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Adrenocortical carcinoma is a rare, aggressive adrenal gland cancer with a poor outlook.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.